ACHV
ACHV
NASDAQ · Biotechnology

Achieve Life Sciences Inc

$3.17
+0.23 (+7.82%)
As of Apr 1, 2:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
27.56B
Net Income
-67,643,315
Gross Margin
-98.8%
Profit Margin
-397.8%
Rev Growth
-44.7%
D/E Ratio
0.47
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -98.8% -98.8% 64.9% 64.9%
Operating Margin -418.8% -376.9% 2.0% 1.9%
Profit Margin -397.8% -377.9% 1.6% 1.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 27.56B 49.82B 656.40M 699.53M
Gross Profit -27,221,047,072 -49,197,627,095 425.96M 453.94M
Operating Income -115,424,846,925 -187,750,519,126 13.43M 13.07M
Net Income -67,643,315 -110,028,887 10.36M 12.63M
Gross Margin -98.8% -98.8% 64.9% 64.9%
Operating Margin -418.8% -376.9% 2.0% 1.9%
Profit Margin -397.8% -377.9% 1.6% 1.8%
Rev Growth -44.7% -44.7% +1.9% +12.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 37.48M 37.48M 15.37M 15.24M
Total Equity 79.63M 79.63M 127.45M 128.08M
D/E Ratio 0.47 0.47 0.12 0.12
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -66,891,601 -114,850,932 18.53M 18.96M
Free Cash Flow 6.70M 12.14M